Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Cancer Prev Res (Phila). 2019 Jul 2;12(9):585–598. doi: 10.1158/1940-6207.CAPR-18-0509

Table 1.

Univariate and multivariate analyses of factors for predicting overall survival in AA prostate cancer patients.

Univariate analysis Multivariate analysis
Variables HR 95% CI P value HR 95% CI P value
miRNA expression (High vs Low) 7.6 1.7–35.3 0.0076 22.4 2.3–222.4 0.0078
Age (≥62 vs <62 years) 2.5 0.8–7.5 0.1 0.2 0.03–1.6 0.1
T classification (T3/T4 versus T2) 1.6 0.3–4.2 0.81 8.9 0.9–85.6 0.057
PSA (<10 vs ≥10) 1.6 0.5–4.9 0.37 0.02 0.0006–1.0 0.048
PSA failure (Positive vs Negative) 1.4 0.4–4.1 0.59 0.7 0.10–4.7 0.68
Gleason Score (8–10 vs 5–7) 2.2 0.8–6.3 0.1 0.44 0.04–4.6 0.49
Univariate and multivariate analyses of factors for predicting overall survival in EA prostate cancer patients.
Univariate analysis Multivariate analysis
Variables HR 95% CI P value HR 95% CI P value
miRNA expression (High vs Low) 1.9 0.6–5.5 0.25 1.1 0.1–8.3 0.91
Age (≥62 vs <62 years) 0.8 0.3–2.5 0.59 0.5 0.1–2.2 0.34
T classification (T3/T4 versus T2) 4.2 1.1–16.0 0.036 2.0 0.2–17.0 0.53
PSA (<10 vs ≥10) 2.1 0.7–6.0 0.17 1.7 0.2–13.3 0.45
PSA failure (Positive vs Negative) 4.7 1.3–17.7 0.02 2.3 0.2–19.1 0.45
Gleason Score (8–10 vs 5–7) 2.1 0.6–8.0 0.25 0.8 0.1–4.0 0.74